Max Robotics — Global Service Robot Directory + US Certification

About

Georgine Lamvu is a leading researcher in minimally invasive gynecologic surgery, with a particular focus on hysterectomy outcomes, pain management, and the impact of regulatory changes on surgical practice. Her work has significantly shaped understanding of how FDA warnings affect clinical decision-making, as demonstrated by her highly cited 2015 study on the association between the FDA morcellation warning and rates of minimally invasive hysterectomy and myomectomy (67 citations). Lamvu has made major contributions to postoperative pain management through randomized controlled trials comparing extended-release versus short-acting bupivacaine for wound infiltration and systematic reviews on paracervical block efficacy. Her research also addresses operative time prediction in robotic versus conventional laparoscopic hysterectomy and explores chronic pelvic pain in veteran populations undergoing hysterectomy. With over 100 cumulative citations across her most influential works, Lamvu’s investigations into surgical techniques and pain control have direct implications for improving patient outcomes and guiding evidence-based surgical practice. Her work on the FDA morcellation warning remains particularly impactful, highlighting the real-world consequences of regulatory actions on surgical approaches.